A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose

Study identifier:PT010018

ClinicalTrials.gov identifier:NCT03250182

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Study to Assess the Pharmacokinetics and Safety of PT010 in Subjects With Moderate to Severe COPD Following Single and Repeat Dose Administration

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

Phase 1

Healthy volunteers

No

Study drug

PT010

Sex

All

Actual enrollment

30

Study type

Interventional

Age

40 Years - 80 Years

Date

Study Start Date: 11 Aug 2017
Primary Completion Date: 07 Dec 2017
Study Completion Date: 07 Dec 2017

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2021 by Pearl Therapeutics, Inc.

Sponsors

Pearl Therapeutics, Inc.

Collaborators

-

Inclusion and exclusion criteria